Rising Pharmaceuticals Recalls Timolol Maleate Ophthalmic Solution Due to Labeling Error
Rising Pharmaceuticals is recalling Timolol Maleate Sterile Ophthalmic Solution due to a carton label mix-up where 0.25% bottles were shipped in 0.5% cartons.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences. The hazard is a minor labeling error (carton mix-up) without reported injuries or illnesses.
Plain-English summary
Rising Pharmaceuticals, Inc. is recalling a specific lot of Timolol Maleate Sterile Ophthalmic Solution USP. The recall was initiated due to a labeling error involving a mix-up of outer cartons.
The issue occurred when a case of Timolol Maleate Sterile Ophthalmic Solution USP 0.25%, 5ml, was packaged with the outer carton intended for Timolol Maleate Sterile Ophthalmic Solution USP 0.5%, 5ml. Although the bottle inside contained the 0.25% concentration, the external packaging indicated the 0.5% concentration. The affected product is Lot # 089A016, with an expiration date of 12/31/2020. The product was distributed nationwide in the U.S.A.
Consumers and healthcare providers should check their inventory for this specific lot number and concentration discrepancy. If the product is found, it should be returned to the pharmacy or distributor for replacement or refund. No adverse health consequences are expected from this labeling error, but accurate dosing is critical for ophthalmic medications.
The recalled product
- Product
- TIMOLOL MALEATE (TIMOLOL MALEATE)
- Brand
- TIMOLOL MALEATE
- Manufacturer
- Rising Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic Solution
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 089A016
- Exp 12/31/2020
UPCs (2)
- 0364980513050
- 0364980514057
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Rising Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · TIMOLOL MALEATE
- ModerateTimolol eye drop caps can lodge a spike in the nozzle
FDA (Drugs) · 2025-08-06
- ModerateTimolol Maleate Ophthalmic Solution Recalled for Defective Container
FDA (Drugs) · 2025-05-14
- ModerateTimolol Maleate eye drops recalled for defective dropper cap
FDA (Drugs) · 2025-02-12
- HighOphthalmic Eye Drops Recalled for Defective Container Cap Spike
FDA (Drugs) · 2024-12-18
- HighTimolol Maleate Eye Drops Recalled Due to Defective Container
FDA (Drugs) · 2024-11-13
Same manufacturer · Rising Pharmaceuticals, Inc.
See all →- LowRising Pharmaceuticals Recalls Timolol Maleate Ophthalmic Solution Due to Labeling Error
FDA (Drugs) · 2020-07-01
- SevereRising Pharmaceuticals Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
- SevereRising Pharmaceuticals Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
- SevereRising Pharmaceuticals Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
- SevereRising Pharmaceuticals Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02